Arbutus Biopharma ABUS
NASDAQ ABUS
$4.78 +0.09 (+1.92%)
At close: Sep 30, 2026 · 4:00 PM EDT

Arbutus Biopharma (ABUS) Accumulated Expenses (2018 - 2019)

Updated

Arbutus Biopharma (ABUS) reported Accumulated Expenses of $137,000 for Q4 2019, down 89.7% from $1.33 million a year earlier and down 32.5% from the prior quarter.

Analysis

Arbutus Biopharma (ABUS) Accumulated Expenses (2018 - 2019) Analysis & Trends

Dating back to Q4 2018, Arbutus Biopharma's Accumulated Expenses record includes 5 quarters.

  • By year, Accumulated Expenses came in at $1.33 million in FY2018.
  • Per Business Quant data, the three quarters before Q4 2019 came in at $203,000 (Q3 2019), $342,000 (Q2 2019) and $982,000 (Q1 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Arbutus Biopharma 944.69 Mn 571.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 137,000.00
Sep 30, 2019 203,000.00
Jun 30, 2019 342,000.00
Mar 31, 2019 982,000.00
Dec 31, 2018 1.33 Mn
API Access

Arbutus Biopharma Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ABUS&period=max&api_key=YOUR_API_KEY